{"id":19679,"date":"2022-06-27T08:15:39","date_gmt":"2022-06-27T15:15:39","guid":{"rendered":"https:\/\/marketdepth.com\/?p=19679"},"modified":"2022-06-27T08:15:41","modified_gmt":"2022-06-27T15:15:41","slug":"hillstream-biopharma-partners-with-sapien-biosciences","status":"publish","type":"post","link":"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/","title":{"rendered":"Hillstream BioPharma Partners with Sapien Biosciences"},"content":{"rendered":"\n

Hillstream BioPharma, Inc. (Nasdaq: HILS)<\/strong> today announced that it has begun a collaboration with Sapien Biosciences to evaluate the synergy of HSB-1216 with immune checkpoint inhibitors.<\/p>\n\n\n\n

\u201cWe are initiating studies, in collaboration with Sapien Biosciences, to determine the synergy between HSB-1216, our ferroptosis inducer and nivolumab, an anti-PD1 antibody.\u201d<\/p>Randy Milby, Hillstream\u2019s Chief Executive Officer<\/cite><\/blockquote>\n\n\n\n

Treatment with immune checkpoint inhibitors (ICIs) induces the effector function of T cells in the tumor microenvironment (TME). Activated T cells accumulated in TME then kill tumor cells mainly by enhancing cell death through the granzyme pathway and by releasing interferon gamma (IFN) from CD8+ T cells, according to the press release.<\/p>\n\n\n\n

\u201cWe are excited to extend our collaboration with Hillstream Biopharma to evaluate potential synergy between their HSB-1216 molecule and ICIs using our expertise in establishing patient tissue-derived cell models in oncology, immunology and Immune-oncology. Previously, Sapien demonstrated potent anti-cancer activity of HSB-1216 in primary triple negative breast cancer cells which were presented at AACR 2020.\u201d<\/p>Dr. Jugnu Jain, CEO, Sapien Biosciences<\/cite><\/blockquote>\n","protected":false},"excerpt":{"rendered":"Hillstream BioPharma, Inc. (Nasdaq: HILS) today announced that it has begun a collaboration with Sapien Biosciences to evaluate the synergy of HSB-1216 with immune checkpoint inhibitors. \u201cWe are initiating studies, in collaboration with Sapien Biosciences, to determine the synergy between HSB-1216, our ferroptosis inducer and nivolumab, an anti-PD1 antibody.\u201d Randy Milby, Hillstream\u2019s Chief Executive Officer… View Article<\/a>","protected":false},"author":3,"featured_media":18750,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":0,"footnotes":""},"categories":[9,10,8,11,16],"tags":[],"acf":[],"yoast_head":"\nHillstream BioPharma Partners with Sapien Biosciences - MarketDepth<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hillstream BioPharma Partners with Sapien Biosciences - MarketDepth\" \/>\n<meta property=\"og:description\" content=\"Hillstream BioPharma, Inc. (Nasdaq: HILS) today announced that it has begun a collaboration with Sapien Biosciences to evaluate the synergy of HSB-1216 with immune checkpoint inhibitors. \u201cWe are initiating studies, in collaboration with Sapien Biosciences, to determine the synergy between HSB-1216, our ferroptosis inducer and nivolumab, an anti-PD1 antibody.\u201d Randy Milby, Hillstream\u2019s Chief Executive Officer... View Article\" \/>\n<meta property=\"og:url\" content=\"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/\" \/>\n<meta property=\"og:site_name\" content=\"MarketDepth\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/marketdepthnews\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-27T15:15:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-27T15:15:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/marketdepth.com\/wp-content\/uploads\/2022\/02\/Meeting-in-front-of-windows-black-and-white.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"MarketDepth\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MarketDepthNews\" \/>\n<meta name=\"twitter:site\" content=\"@MarketDepthNews\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"MarketDepth\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/\"},\"author\":{\"name\":\"MarketDepth\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69\"},\"headline\":\"Hillstream BioPharma Partners with Sapien Biosciences\",\"datePublished\":\"2022-06-27T15:15:39+00:00\",\"dateModified\":\"2022-06-27T15:15:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/\"},\"wordCount\":174,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/marketdepth.com\/#organization\"},\"articleSection\":[\"Biotechnology\",\"Breaking\",\"Healthcare\",\"Investing\",\"What's Hot\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/\",\"url\":\"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/\",\"name\":\"Hillstream BioPharma Partners with Sapien Biosciences - MarketDepth\",\"isPartOf\":{\"@id\":\"https:\/\/marketdepth.com\/#website\"},\"datePublished\":\"2022-06-27T15:15:39+00:00\",\"dateModified\":\"2022-06-27T15:15:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/marketdepth.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hillstream BioPharma Partners with Sapien Biosciences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/marketdepth.com\/#website\",\"url\":\"https:\/\/marketdepth.com\/\",\"name\":\"MarketDepth\",\"description\":\"Stock Market News & Headlines\",\"publisher\":{\"@id\":\"https:\/\/marketdepth.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/marketdepth.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/marketdepth.com\/#organization\",\"name\":\"MarketDepth\",\"url\":\"https:\/\/marketdepth.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg\",\"contentUrl\":\"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg\",\"width\":1500,\"height\":1000,\"caption\":\"MarketDepth\"},\"image\":{\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/marketdepthnews\",\"https:\/\/twitter.com\/MarketDepthNews\",\"https:\/\/www.instagram.com\/marketdepth\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69\",\"name\":\"MarketDepth\",\"url\":\"https:\/\/marketdepth.com\/author\/3\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hillstream BioPharma Partners with Sapien Biosciences - MarketDepth","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/","og_locale":"en_US","og_type":"article","og_title":"Hillstream BioPharma Partners with Sapien Biosciences - MarketDepth","og_description":"Hillstream BioPharma, Inc. (Nasdaq: HILS) today announced that it has begun a collaboration with Sapien Biosciences to evaluate the synergy of HSB-1216 with immune checkpoint inhibitors. \u201cWe are initiating studies, in collaboration with Sapien Biosciences, to determine the synergy between HSB-1216, our ferroptosis inducer and nivolumab, an anti-PD1 antibody.\u201d Randy Milby, Hillstream\u2019s Chief Executive Officer... View Article","og_url":"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/","og_site_name":"MarketDepth","article_publisher":"https:\/\/www.facebook.com\/marketdepthnews","article_published_time":"2022-06-27T15:15:39+00:00","article_modified_time":"2022-06-27T15:15:41+00:00","og_image":[{"width":1920,"height":1280,"url":"https:\/\/marketdepth.com\/wp-content\/uploads\/2022\/02\/Meeting-in-front-of-windows-black-and-white.jpg","type":"image\/jpeg"}],"author":"MarketDepth","twitter_card":"summary_large_image","twitter_creator":"@MarketDepthNews","twitter_site":"@MarketDepthNews","twitter_misc":{"Written by":"MarketDepth","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/#article","isPartOf":{"@id":"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/"},"author":{"name":"MarketDepth","@id":"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69"},"headline":"Hillstream BioPharma Partners with Sapien Biosciences","datePublished":"2022-06-27T15:15:39+00:00","dateModified":"2022-06-27T15:15:41+00:00","mainEntityOfPage":{"@id":"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/"},"wordCount":174,"commentCount":0,"publisher":{"@id":"https:\/\/marketdepth.com\/#organization"},"articleSection":["Biotechnology","Breaking","Healthcare","Investing","What's Hot"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/","url":"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/","name":"Hillstream BioPharma Partners with Sapien Biosciences - MarketDepth","isPartOf":{"@id":"https:\/\/marketdepth.com\/#website"},"datePublished":"2022-06-27T15:15:39+00:00","dateModified":"2022-06-27T15:15:41+00:00","breadcrumb":{"@id":"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/marketdepth.com\/hillstream-biopharma-partners-with-sapien-biosciences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/marketdepth.com\/"},{"@type":"ListItem","position":2,"name":"Hillstream BioPharma Partners with Sapien Biosciences"}]},{"@type":"WebSite","@id":"https:\/\/marketdepth.com\/#website","url":"https:\/\/marketdepth.com\/","name":"MarketDepth","description":"Stock Market News & Headlines","publisher":{"@id":"https:\/\/marketdepth.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/marketdepth.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/marketdepth.com\/#organization","name":"MarketDepth","url":"https:\/\/marketdepth.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/","url":"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg","contentUrl":"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg","width":1500,"height":1000,"caption":"MarketDepth"},"image":{"@id":"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/marketdepthnews","https:\/\/twitter.com\/MarketDepthNews","https:\/\/www.instagram.com\/marketdepth\/"]},{"@type":"Person","@id":"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69","name":"MarketDepth","url":"https:\/\/marketdepth.com\/author\/3\/"}]}},"_links":{"self":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/19679"}],"collection":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/comments?post=19679"}],"version-history":[{"count":1,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/19679\/revisions"}],"predecessor-version":[{"id":19680,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/19679\/revisions\/19680"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/media\/18750"}],"wp:attachment":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/media?parent=19679"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/categories?post=19679"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/tags?post=19679"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}